Ftse Mib
38.655,09
0,08%
DAX
22.551,43
0,12%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
1,63%
Bitcoin
85.473,09
1,31%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Skye Bioscience Inc (SKYE) Skye Bioscience Inc (SKYE) Notizie

Skye Bioscience Inc

SKYE
2,71
0,03 (1,12%)
28 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/3/202500:54EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
27/2/202501:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202523:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202523:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202523:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202523:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202523:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202523:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202523:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202523:27EDGAR2Form 8-K - Current report
20/12/202400:09EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
20/11/202414:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202403:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202423:31EDGAR2Form 144 - Report of proposed sale of securities
15/11/202423:25EDGAR2Form 144 - Report of proposed sale of securities
15/11/202423:22EDGAR2Form 144 - Report of proposed sale of securities
14/11/202415:21EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/11/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:03EDGAR2Form 8-K - Current report
31/10/202401:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202401:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202422:25EDGAR2Form 8-K - Current report
24/10/202422:59EDGAR2Form 8-K - Current report
23/9/202423:25EDGAR2Form DEF 14A - Other definitive proxy statements
14/9/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202423:18EDGAR2Form PRE 14A - Other preliminary proxy statements
05/9/202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202423:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/8/202423:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202423:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/7/202413:30GLOBEBeacon Biosignals Announces Strategic Collaboration with..
10/6/202415:27EDGAR2Form 8-K - Current report
17/5/202422:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/5/202422:19EDGAR2Form S-3 - Registration statement under Securities Act of..
10/5/202422:17EDGAR2Form S-3 - Registration statement under Securities Act of..
10/5/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 2,73 Min: 2,65 Max: 2,85
Chiusura: 2,68

La tua Cronologia

NASDAQ
SKYE
Skye Bioscience
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci